Decreased Expression of Pro-Carcinogenic Genes Following Tacrolimus to Sirolimus Conversion in Liver Transplant Recipients.

被引：0
|
作者：
Bhat, M. [1 ]
Pasini, E. [1 ]
Baciu, C. [1 ]
Kurian, S. [2 ]
Levitsky, J. [3 ]
机构：
[1] Univ Hlth Network, Multi Organ Transplant Program, Toronto, ON, Canada
[2] Scripps Res Inst, Dept Mol & Expt Med, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA
[3] Northwestern Univ, Dept Med, Div Gastroenterol & Hepatol, Chicago, IL 60611 USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2018年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
B355
引用
收藏
页码：753 / 753
页数：1
相关论文
共 50 条
  • [1] Decreased expression of pro-carcinogenic genes following tacrolimus to sirolimus conversion in liver transplant recipients
    Bhat, M.
    Pasini, E.
    Baciu, C.
    Kurian, S. M.
    Levitsky, J.
    [J]. TRANSPLANTATION, 2018, 102 : 154 - 155
  • [2] Conversion of calcineurin inhibitors to sirolimus in liver transplant recipients.
    Mies, Sergio
    Beduschi, Thiago
    Silva, Vinicius M. R.
    Mies, Ana Olga N. G. F.
    Della Guardia, Bianca
    Baia, Carlos E. S.
    de Almeida, Marcio D.
    [J]. LIVER TRANSPLANTATION, 2007, 13 (06) : S189 - S189
  • [3] Evaluation of the Conversion from Tacrolimus to Sirolimus in Liver Transplant Recipients
    Bakhtiari, H.
    Todd, S.
    Snyder, H.
    Lo, D.
    Flynn, M.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 759 - 759
  • [4] IMMUNOREGULATORY EFFECTS OF CONVERSION FROM TACROLIMUS TO SIROLIMUS IN LIVER TRANSPLANT RECIPIENTS
    Levitsky, Josh
    Mathew, James M.
    Flaa, Catherine W.
    Rosen, Anne
    Tambur, Anat R.
    Miller, Joshua
    [J]. HEPATOLOGY, 2009, 50 (04) : 568A - 568A
  • [5] SYSTEMIC IMMUNOREGULATORY EFFECTS OF TACROLIMUS TO SIROLIMUS CONVERSION IN LIVER TRANSPLANT RECIPIENTS
    Levitsky, Josh
    Miller, Joshua
    Tambur, Anat R.
    Abdul-Nabi, Anmaar
    Yang, Guang-Yu
    Chandrasekaran, Dhivya
    Herrera, Nancy
    Al-Saden, Patrice C.
    Mathew, James M.
    [J]. HEPATOLOGY, 2011, 54 : 637A - 637A
  • [6] Improvement in renal function following introduction of sirolimus in liver transplant recipients.
    Laura, ML
    Gores, GJ
    Kremers, WK
    Wiesner, RH
    Brandhagen, DJ
    Menon, KVN
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 364 - 364
  • [7] PREDICTORS OF PROTEINURIA FOLLOWING SIROLIMUS CONVERSION IN LIVER TRANSPLANT RECIPIENTS
    Wadei, Hani
    Zaky, Ziad S.
    Kedveny, Andrew P.
    Mai, Martin
    Taner, Burcin
    Perry, Dana
    Rosser, Barry
    Gonwa, Thomas A.
    [J]. HEPATOLOGY, 2010, 52 (04) : 834A - 834A
  • [8] Systemic immunoregulatory and proteogenomic effects of tacrolimus to sirolimus conversion in liver transplant recipients
    Levitsky, Josh
    Mathew, James M.
    Abecassis, Michael
    Tambur, Anat
    Leventhal, Joseph
    Chandrasekaran, Dhivya
    Herrera, Nancy
    Al-Saden, Patrice
    Gallon, Lorenzo
    Abdul-Nabi, Anmaar
    Yang, Guang-Yu
    Kurian, Sunil M.
    Salomon, Daniel R.
    Miller, Joshua
    [J]. HEPATOLOGY, 2013, 57 (01) : 239 - 248
  • [9] Conversion from Tacrolimus to Sirolimus May Increase the Risk of Cardiovascular Events in Kidney Transplant Recipients.
    Kim, M.
    Pavlakis, M.
    Rogers, C.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 184 - 184
  • [10] Timing of sirolimus conversion influences recovery of renal function in liver transplant recipients.
    Rogers, Christin
    Johnson, Scott
    Gribbons, Megan
    Khwaja, Khalid
    Karp, Seth
    Egbuna, Cigo
    Mandelbrot, Dirtier
    Pavlakis, Martha
    Hanto, Douglas
    Curry, Michael
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 312 - 313
12345